Keytruda
-
重磅！默沙东皮下注射Keytruda获FDA批准
正文共：2000字 2图 预计阅读时间：6分钟 重磅消息！ 美国食品药品监督管理局（FDA）近日批准了默沙东旗下明星抗癌药Keytruda的皮下注射剂型。这一全新给药方式将患者每…
-
Merck & Co. is laying off 6,000 employees, and the reason is…
DrugTimes team will continue to follow and report. Please stay tuned. Many thanks!
-
Former U.S. President Jimmy Carter passed away at the age of 100 | Once on the brink of death, saved by Keytruda
One of President Carter’s most notable achievements was the formal establishment of diplomatic relations between China and the United States during his tenure
-
One good drug can change fate! Summit’s stock price soars by 119%, with its market value increasing more than a hundredfold
For upcoming reports, please follow DrugTimes
-
Merck Halts Two Phase III Clinical Trials
Drug development is not easy, and we pay tribute to the heroes of innovative drug development!
-
Top 10 best-selling oncology drugs
The bright past is worth learning from by R&D personnel of later generations and their role and responsibility is to realize the commercialization of today’s cutting-edge technologies
-
As the 10th anniversary of approval approaches，Keytruda adds ‘potential’ performance to Merck
DrugTimes will follow up on this subject. Please stay tuned
-
Is it too early for Akeso and Summit to celebrate? Merck executive comments on the explosive news that Keytruda has been successfully challenged
Just our two cents. All comments, including criticisms, are warmly welcome. Thank you all very much!
-
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Tri…
-
最新汇总！2020获批的PD-1/L1疗法，囊括13类癌症
本文转自：环宇达康，药时代授权转载，衷心感谢！点击阅读原文 免疫疗法是攻克癌症的希望，通过激活人体自身的免疫系统攻击癌症的方式已被证实可以用于所有的实体肿瘤，这种旨在充分利用人体自…
